The purpose of this study is to determine whether 5% human albumin solution, given to correct
hypoalbuminemia, could improve organ dysfunction in burn patients as assessed by a change in
the SOFA score from baseline to day 7 (or before if the patient is discharged from the ICU or
died).
Phase:
Phase 4
Details
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborator:
Centre de Recherche du Centre Hospitalier de l'Université de Montréal